维普中文期刊产品整合服务
64篇 您的检索式:作者名="Parés"
    题名 作者 年代 出处 被引量
1Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid显示文摘Parés A Caballeria L Rodés J Gastroenterology0,,:2
2Effects of CYP2C19genotype on outcomes of clopidogrel treatment显示文摘ParéG Mehta SR Yusuf S 2010N Engl J Med2010,363,18:1
3Nitrogen net mineralization and dynamics following whole tree harvesting and winter windrowing on clayey sites of northwestern Quebec显示文摘Braisa S Paré D Camiré C 0,,:1
4Laparoscopic right colectomy: a systematic review and meta-analysis of observational studies comparing two types of anastomosis显示文摘P. Carnuccio J. Jimeno D. Parés 2014Techniques in Coloproctology2014,,1:1
5Management of osteoporosisin liver disease显示文摘Gua?abens N Parés A 2011Clin Res Hepatol Gastroenterol2011,35,67:1
6Randomized clinical trial comparing inflammatory and angiogenic response after open versus laparoscopic curative resection for colonic cancer显示文摘Pascual M Alonso S Parés D 0,,01:1
7Effects of CYP2C19 genotype on outcomes of clopidogrel treatment显示文摘ParéG Mehta SR Yusuf S 2010N Engl J Med2010,363,18:1
8Extracorporeal liver support in severe alcoholic hepatitis显示文摘The severity of alcoholic hepatitis(AH) which may coexist with cirrhosis varies greatly, from asymptomatic forms which are detected in alcoholic patients without any sign of liver disease, except laboratory abnormalities, to severe forms characterised by deep jaundice, ascites, hepatic encephalopathy and low prothrombin index. In hospitalized patients the mortality could be as high as 75%. The elevated number of therapeutic proposals reported for more than forty years reveals the lack of efficacy of a particular modality. Even in the most favorable trials, the survival is already very poor and in some cases related to the development of renal failure or hepatorenal syndrome. There are some motivating reports concerning albumin dialysis as a support treatment in patients with severe AH, either alone or in combination with other pharmacological therapies. The favorable effects of albumin dialysis in patients with severe AH suggest that the procedure used alone or in combination with other therapies may have a role in this clinical condition. This will be particularly relevant to offer an alternative therapy in these patients, thus being a potential bridge to recovery or to be listed for liver transplantation.Albert Parés Antoni Mas 2014World Journal of Gastroenterology2014,20,25:1
9Natural history of primary biliary cirrhosis显示文摘Parés A Rodés J 2003Clin Liver Dis2003,7,4:1
10Quantitative assessment of bronchial wall attenuation with thin-section CT:An indicator of airflow limitation in chronic obstructive pulmonary disease显示文摘Yamashiro T Matsuoka S Estépar RS 0,,02:1
11Randomized clinical trial comparing inflammatory and angiogenic response after open versus laparoseopic curative resection for colonic cancer显示文摘Pascual M Alonso S Parés D 2011Br J Surg2011,98,1:1
127-Azetidinylquinolones as antibacterial agents, synthesis and structure-activity relationships显示文摘Frigola J Parés J Corbera J 1993J Med Chem1993,36,7:1
13Randomized clinical study of gastrografin administration in patients with adhesive small bowel obstruction显示文摘Biondo S Paré s D Mora L 0,,05:1
14Effects of CYP2C19 genotype on outcomes of clopidogrel treatment显示文摘Paré G Mehta SR Yusuf S 2010N Engl J Med2010,363,18:1
15Adaptation and valida-tion of the Bristol scale stool form translated into the Spanish lan-guage among health professionals and patients显示文摘Parés D Comas M Dorcaratto D 2009Rev Esp En-ferm Dig2009,101,5:1
16Alcohol dehydrogenase from human stomach: variability in normal mucosa and effect of age, gender, ADH3 phenotype and gastric region显示文摘Moreno A Parés A Ortiz J Enriquez J Parés X 1994Alcohol Alcohol1994,29,6:2
17Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease显示文摘Glucosamine and chondroitin sulfate are molecules involved in the formation of articular cartilage and are frequently used for symptom relief in patients with arthrosis.These molecules are well tolerated with scarce secondary effects.Very few cases of possible hepatotoxicity due to these substances have been described.The aim of this paper is to report the frequency of presumed glucosamine hepatotoxicity in patients with liver disease.A questionnaire was given to 151 consecutive patients with chronic liver disease of different etiology(mean age 59 years,56.9%women)attended in an outpatient clinic with the aim of evaluating the frequency of consumption of these drugs and determine whether their use coincided with a worsening in liver function test results.Twenty-three patients(15.2%)recognized having taken products containing glucosamine or chondroitin sulfate previously or at the time of the questionnaire.Review of the clinical records and liver function tests identified 2 patients presenting an elevation in aminotransferase values temporarily associated with glucosamine treatment;one of the cases simultaneously presented a skin rash attributed to the drug.Review of these two patients and the cases described in the literature suggest toxicity of glucosamine and chondroitin sulfate.The clinical spectrum is variable,and the mechanism of toxicity is not clear but may involve reactions of hypersensitivity.The consumption of products containing glucosamine and/or chondroitin sulfate is frequent among patients with chronic liver diseases and should be taken into account on the appearance of alterations in liver function tests not explained by the underlying disease.Cristian Cerda Miguel Bruguera Albert Parés 2013World Journal of Gastroenterology2013,19,32:2
18Evolution of magnetic fabric during incipient deformation of mudrocks (Pyreness,Northern Spain)显示文摘Parés J P van der Pluijm B A Dinarés-Turell J 1999Tectonophysics1999,307,:1
19Novel loci,including those related to Crohn disease,psoriasis,and inflammation,identified in a genome-wide association study of fibrinogen in 17 686 women:the Women′s Genome Health Study显示文摘Danik J S Paré G Chasman D I 2009Circ Cardiovasc Genet2009,2,2:1
20Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis显示文摘Marin ND París SC Vélez VM 2010Tuberculosis (Edinb)2010,90,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费